Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bialanx
AddedFeb 18, 2024
UpdatedJun 18, 2026
Bialanx

Bialanx

Bialanx: Pioneering real-time, label-free bioelectronic detection platforms using consumer CMOS technology.

HQ
New York City, NY, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded in New York, Bialanx is dedicated to pioneering real-time, label-free bioelectronic detection platforms utilizing consumer CMOS technology. Their core mission is to revolutionize biochemical applications by providing innovative solutions for the detection of proteins and nucleic acids. By leveraging the exponential advancements in integrated circuit technology, Bialanx aims to offer powerful, low-cost biosensing solutions that can be mass-produced, thus opening new avenues in the field of biochemical detection.

Bialanx has attracted notable investors and industry experts who recognize the transformative potential of their technology. Their key achievements include the successful development and demonstration of their bioelectronic detection platform, which has garnered attention for its real-time capabilities and cost-effectiveness. The overall impact of Bialanx's innovations lies in their potential to significantly advance biochemical research and diagnostics, making sophisticated detection methods more accessible and efficient.

Bialanx - Similar Companies

Quicksilver Biosciences logo

Quicksilver Biosciences

InSilixa logo

InSilixa

CytoTronics logo

CytoTronics

cytotronics.com

Carmolex logo

Carmolex

BioSens8 logo

BioSens8

biosens8.com

NorthShore Bio logo

NorthShore Bio

NanoDetection Technology logo

NanoDetection Technology

Innovative Biosensors logo

Innovative Biosensors

Electronic Biosciences logo

Electronic Biosciences

electronicbio.com

ConquerX logo

ConquerX

conquerxlab.com

eGlint logo

eGlint

Biolinq logo

Biolinq

PreDxion Bio logo

PreDxion Bio

predxionbio.com

Diagnostic Biochips logo

Diagnostic Biochips

NanoMosaic logo

NanoMosaic

Bialanx - Quick Facts

Who are Bialanx's competitors?

Companies similar to Bialanx include Quicksilver Biosciences, InSilixa, CytoTronics and Carmolex.

When was Bialanx founded?

Bialanx was founded in 2011.

Where is Bialanx's headquarters located?

Bialanx's headquarters is located in New York City, NY, US.

When was Bialanx's last funding round?

Bialanx's most recent funding round was for $150k (USD) in May 2013.

How much has Bialanx raised to-date?

As of May 6, 2013, Bialanx has raised a total of $150k (USD).

How many employees does Bialanx have?

Bialanx has 5 employees as of Feb 4, 2024.

Bialanx - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Bioelectronic Detection
Tags
  • CMOS
  • Research
NAICS
  • 334400Semiconductor and Other Electronic Component Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 334410Semiconductor and Other Electronic Component Manufacturing
SIC
  • 3674Semiconductors And Related Devices
  • 3600Electronic And Other Electrical Equipment And Components, Except Computer
  • 3670Electronic Components And Accessories
Show 1 more industry code
SIC
  • 3900Miscellaneous Manufacturing Industries